Tobias Neumann-Haefelin Selected Research

Tobias Neumann-Haefelin Research Topics

Disease

21	Stroke (Strokes) 08/2021 - 08/2004
8	Ischemic Stroke 01/2020 - 10/2007
5	Infarction (Infarctions) 09/2010 - 01/2004
4	Cerebral Hemorrhage 01/2020 - 08/2006
4	Atrial Fibrillation 01/2016 - 07/2014
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 10/2007
3	Hemorrhage 01/2020 - 10/2015
3	Brain Ischemia (Cerebral Ischemia) 11/2009 - 10/2005
2	Hematoma 01/2020 - 02/2015
2	Pathologic Constriction (Stenosis) 10/2010 - 03/2010
2	Ischemia 10/2010 - 11/2007
2	Brain Injuries (Brain Injury) 10/2010 - 11/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2007 - 07/2005
1	Drug-Related Side Effects and Adverse Reactions 10/2015
1	Thrombosis (Thrombus) 10/2015
1	Transient Ischemic Attack 02/2013
1	Embolic Stroke 01/2013
1	Lymphopenia (Lymphocytopenia) 11/2009
1	Hypoxia (Hypoxemia) 11/2007
1	Demyelinating Diseases (Demyelinating Disease) 12/2006
1	Vomiting 05/2004

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 01/2017 - 07/2014
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 10/2005
4	Vitamin K FDA Link 01/2017 - 07/2014
3	Dabigatran FDA Link 01/2020 - 10/2015
3	N(4)-oleylcytosine arabinosideIBA 01/2016 - 01/2015
3	Pharmaceutical PreparationsIBA 10/2015 - 12/2009
2	edoxabanIBA 10/2015 - 10/2015
2	apixabanIBA 10/2015 - 10/2015
2	RivaroxabanIBA 10/2015 - 10/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2010 - 11/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2010 - 11/2007
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2007 - 10/2005
2	Biomarkers (Surrogate Marker)IBA 07/2005 - 09/2004
1	idarucizumabIBA 01/2020
1	AntidotesIBA 01/2016
1	Thrombin FDA Link 10/2015
1	Factor Xa (Coagulation Factor Xa)IBA 10/2015
1	CreatinineIBA 07/2014
1	prolinedithiocarbamate (PDTC)IBA 09/2010
1	AntioxidantsIBA 09/2010
1	NF-kappa B (NF-kB)IBA 09/2010
1	pyrrolidine dithiocarbamic acidIBA 09/2010
1	p38 Mitogen-Activated Protein KinasesIBA 09/2010
1	SphingolipidsIBA 04/2010
1	microplasminIBA 12/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2009
1	LipidsIBA 11/2009
1	SphingosineIBA 11/2009
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2009
1	CytokinesIBA 11/2009
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2009
1	Oxidoreductases (Dehydrogenase)IBA 11/2007
1	Clostridium difficile lethal toxin BIBA 11/2007
1	Atorvastatin (Lipitor)FDA Link 11/2007
1	Coenzyme A (CoA)IBA 11/2007
1	1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA 12/2006
1	Indicators and Reagents (Reagents)IBA 11/2006
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2006
1	Proteins (Proteins, Gene)FDA Link 09/2004
1	N-acetylaspartate (N-acetyl aspartate)IBA 08/2004
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2004
1	thiamine triphosphorate (TTP)IBA 01/2004

Therapy/Procedure

13	Therapeutics 08/2021 - 08/2006
4	Thrombolytic Therapy 05/2009 - 07/2007
3	Length of Stay 01/2020 - 12/2012
2	Thrombectomy 12/2020 - 04/2016
2	Stents 10/2010 - 03/2010
1	Anticoagulation Reversal 02/2015
1	Secondary Prevention 07/2014
1	General Anesthesia 01/2013
1	Drug Therapy (Chemotherapy) 12/2012
1	Aftercare (After-Treatment) 03/2010
1	Contraindications 05/2004